Home LiteratureArticle Details
PMID: 12759250 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.

The American journal of pathology ·Vol. 162 ·No. 6 ·2003-06-00 ·Pages 1937-49

Cheng S, Lovett DH

Abstract

Progressive renal interstitial fibrosis and tubular atrophy represent the final injury pathway for all commonly encountered forms of renal disease that lead to end-stage renal failure. It has been recently recognized that myofibroblastic cells are the major contributors to the deposition of interstitial collagens. While there are several potential cellular sources of myofibroblasts, attention has focused on the transformation of the organized tubular epithelium to the myofibroblastic phenotype, a process potently driven both in vitro and in vivo by transforming growth factor-beta1 (TGF-beta1). Integrity of the underlying basal lamina provides cellular signals that maintain the epithelial phenotype, and disruption by discrete proteases could potentially initiate the transformation process. We demonstrate that TGF-beta1 coordinately stimulates the synthesis of a specific matrix metalloproteinase, gelatinase A (MMP-2), and its activator protease, MT1-MMP (MMP-14), and that active gelatinase A is absolutely required for epithelial-mesenchymal transformation induced by TGF-beta1. In addition, purified active gelatinase A alone is sufficient to induce epithelial-mesenchymal transformation in the absence of exogenous TGF-beta1. Gelatinase A may also mediate epithelial-mesenchymal transformation in a paracrine manner through the proteolytic generation of active TGF-beta1 peptide. MT1-MMP and gelatinase A were co-localized to sites of active epithelial-mesenchymal transformation and basal lamina disruption in the rat remnant kidney model of progressive renal fibrosis. These studies indicate that a discrete matrix metalloproteinase, gelatinase A, is capable of inducing the complex genetic rearrangements that characterize renal tubular epithelial-mesenchymal transformation.

MeSH Terms
Actins/analysis Animals Cell Communication/physiology Cell Differentiation/drug effects Cell Line Cell Movement/drug effects Dose-Response Relationship, Drug Epithelial Cells/cytology,drug effects Immunohistochemistry Kidney Tubules/cytology,drug effects,metabolism Luciferases/genetics,metabolism Male Matrix Metalloproteinase 2/metabolism,pharmacology Matrix Metalloproteinase Inhibitors Matrix Metalloproteinases, Membrane-Associated Mesoderm/chemistry,cytology,drug effects Metalloendopeptidases/genetics,metabolism Muscle, Smooth/chemistry Rats Rats, Wistar Recombinant Fusion Proteins/genetics,metabolism Transforming Growth Factor beta/genetics,pharmacology Transforming Growth Factor beta1
Chemicals
Actins Matrix Metalloproteinase Inhibitors Recombinant Fusion Proteins Tgfb1 protein, rat Transforming Growth Factor beta Transforming Growth Factor beta1 Luciferases Matrix Metalloproteinases, Membrane-Associated Metalloendopeptidases Matrix Metalloproteinase 2
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cheng Sunfa
Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California, San Francisco 94121, USA.
Lovett David H
References (80)
80 references, click to expand
  1. Interstitial myofibroblasts in experimental renal infection and scarring.
    Am J Nephrol. 1995;15(5):411-7 PMID: 7503141
  2. Myofibroblasts and the progression of experimental glomerulonephritis.
    Exp Nephrol. 1995 Sep-Oct;3(5):308-18 PMID: 7583053
  3. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.
    Nat Med. 1996 Apr;2(4):418-23 PMID: 8597951
  4. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.
    J Clin Invest. 1996 Feb 15;97(4):1094-101 PMID: 8613533
  5. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).
    FEBS Lett. 1996 May 6;385(3):238-40 PMID: 8647259
  6. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
    J Biol Chem. 1996 Apr 12;271(15):9135-40 PMID: 8621565
  7. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.
    Lab Invest. 1996 Jun;74(6):991-1003 PMID: 8667617
  8. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Cancer Res. 1996 Jun 15;56(12):2707-10 PMID: 8665498
  9. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation.
    J Biol Chem. 1996 Jun 21;271(25):15074-83 PMID: 8663054
  10. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.
    Kidney Int Suppl. 1996 May;54:S39-45 PMID: 8731193
  11. Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis.
    Kidney Int. 1996 Jul;50(1):148-55 PMID: 8807583
  12. Transforming growth factor-beta 1 expression and myofibroblast formation during arterial repair.
    Arterioscler Thromb Vasc Biol. 1996 Oct;16(10):1298-305 PMID: 8857928
  13. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
    J Biochem. 1996 Feb;119(2):209-15 PMID: 8882706
  14. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
    J Biol Chem. 1997 Jan 24;272(4):2446-51 PMID: 8999957
  15. Myofibroblasts and the progression of diabetic nephropathy.
    Nephrol Dial Transplant. 1997 Jan;12(1):43-50 PMID: 9027772
  16. Epithelial-mesenchymal transitions in cancer progression.
    Acta Anat (Basel). 1996;156(3):217-26 PMID: 9124038
  17. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats.
    Kidney Int. 1998 Sep;54(3):864-76 PMID: 9734611
  18. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.
    Science. 1999 Jun 4;284(5420):1667-70 PMID: 10356396
  19. Myofibroblasts. I. Paracrine cells important in health and disease.
    Am J Physiol. 1999 Jul;277(1 Pt 1):C1-9 PMID: 10409103
  20. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium.
    J Biol Chem. 1999 Aug 6;274(32):22679-85 PMID: 10428849
  21. Tumor targeting with a selective gelatinase inhibitor.
    Nat Biotechnol. 1999 Aug;17(8):768-74 PMID: 10429241
  22. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells.
    J Biol Chem. 1999 Oct 8;274(41):29130-7 PMID: 10506168
  23. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.
    Kidney Int. 1999 Oct;56(4):1455-67 PMID: 10504497
  24. The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Functional interpretation of morphologic findings.
    Klin Wochenschr. 1981 Sep 15;59(18):1043-51 PMID: 7300233
  25. Enhanced expression of "muscle-specific" actin in glomerulonephritis.
    Kidney Int. 1992 May;41(5):1134-42 PMID: 1351954
  26. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
    Nature. 1992 Nov 26;360(6402):361-4 PMID: 1280332
  27. Evidence for C-type natriuretic peptide production in the rat kidney.
    Biochem Biophys Res Commun. 1993 Apr 30;192(2):532-8 PMID: 8484764
  28. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts.
    J Cell Biol. 1993 Jul;122(1):103-11 PMID: 8314838
  29. Contractile cells of the kidney in primary glomerular disorders: an immunohistochemical study using an anti-alpha-smooth muscle actin monoclonal antibody.
    Hum Pathol. 1993 Jul;24(7):710-6 PMID: 8319951
  30. Mechanisms of tubulo-interstitial injury in progressive renal diseases.
    Eur J Clin Invest. 1993 May;23(5):259-65 PMID: 8354331
  31. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts.
    J Cell Physiol. 1993 Nov;157(2):408-12 PMID: 8227170
  32. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase.
    Am J Pathol. 1994 Jan;144(1):82-94 PMID: 8291614
  33. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5.
    J Cell Biol. 2000 Feb 7;148(3):615-24 PMID: 10662785
  34. Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade.
    Cancer Lett. 2000 Sep 1;157(2):115-21 PMID: 10936671
  35. Induction and regulation of epithelial-mesenchymal transitions.
    Biochem Pharmacol. 2000 Oct 15;60(8):1091-9 PMID: 11007946
  36. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior.
    Am J Pathol. 1997 Feb;150(2):483-95 PMID: 9033265
  37. Role of intermediate filaments in migration, invasion and metastasis.
    Cancer Metastasis Rev. 1996 Dec;15(4):507-25 PMID: 9034607
  38. TGF-beta in kidney fibrosis: a target for gene therapy.
    Kidney Int. 1997 May;51(5):1388-96 PMID: 9150449
  39. Interstitial myofibroblasts: predictors of progression in membranous nephropathy.
    J Clin Pathol. 1997 Feb;50(2):123-7 PMID: 9155692
  40. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.
    Science. 1997 Jul 11;277(5323):225-8 PMID: 9211848
  41. Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation.
    FEBS Lett. 1997 Aug 4;412(3):568-72 PMID: 9276468
  42. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1.
    J Biol Chem. 1997 Sep 5;272(36):22905-12 PMID: 9278454
  43. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.
    J Mol Cell Cardiol. 1997 Aug;29(8):2233-44 PMID: 9281454
  44. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism.
    Kidney Int. 1997 Sep;52(3):637-47 PMID: 9291182
  45. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair.
    Semin Nephrol. 1997 Sep;17(5):467-91 PMID: 9316215
  46. Transformation of rat inner medullary fibroblasts to myofibroblasts in vitro.
    Kidney Int. 1997 Nov;52(5):1279-90 PMID: 9350651
  47. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.
    J Cell Biol. 1997 Dec 29;139(7):1861-72 PMID: 9412478
  48. Hypoxia regulates endothelin-1 production by the inner medullary collecting duct.
    J Lab Clin Med. 1998 Jan;131(1):45-8 PMID: 9452126
  49. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
    Eur J Biochem. 1997 Dec 15;250(3):751-7 PMID: 9461298
  50. Progressive renal disease: the chronic hypoxia hypothesis.
    Kidney Int Suppl. 1998 Apr;65:S74-8 PMID: 9551436
  51. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Biochem J. 1998 Sep 1;334 ( Pt 2):345-53 PMID: 9716492
  52. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    EMBO J. 2000 Oct 2;19(19):5178-93 PMID: 11013220
  53. Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions.
    Dev Biol. 2000 Nov 15;227(2):606-17 PMID: 11071778
  54. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
    J Biol Chem. 2001 Mar 9;276(10):6983-92 PMID: 11114293
  55. Substrate hydrolysis by matrix metalloproteinase-9.
    J Biol Chem. 2001 Jun 8;276(23):20572-8 PMID: 11279151
  56. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta.
    Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6686-91 PMID: 11390996
  57. A substrate phage enzyme-linked immunosorbent assay to profile panels of proteases.
    Anal Biochem. 2001 Jul 15;294(2):176-84 PMID: 11444814
  58. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo.
    J Cell Biol. 2001 Sep 3;154(5):1069-79 PMID: 11535623
  59. Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation.
    J Biol Chem. 2001 Sep 14;276(37):34486-94 PMID: 11432852
  60. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation.
    Am J Pathol. 2001 Oct;159(4):1313-21 PMID: 11583959
  61. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.
    Am J Pathol. 2001 Oct;159(4):1465-75 PMID: 11583974
  62. MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function.
    J Biol Chem. 2001 Oct 26;276(43):40215-24 PMID: 11500488
  63. Contribution of MT1-MMP and of human laminin-5 gamma2 chain degradation to mammary epithelial cell migration.
    J Cell Sci. 2001 Aug;114(Pt 16):2967-76 PMID: 11686300
  64. A unique substrate recognition profile for matrix metalloproteinase-2.
    J Biol Chem. 2002 Feb 8;277(6):4485-91 PMID: 11694539
  65. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.
    Am J Pathol. 2002 Jul;161(1):183-93 PMID: 12107103
  66. Remnant kidney hypermetabolism and progression of chronic renal failure.
    Am J Physiol. 1988 Feb;254(2 Pt 2):F267-76 PMID: 3344809
  67. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.
    Nature. 1990 Jul 26;346(6282):371-4 PMID: 2374609
  68. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
    Eur J Biochem. 1990 Dec 27;194(3):721-30 PMID: 2269296
  69. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma.
    Cancer Res. 1991 Jun 1;51(11):2973-8 PMID: 2032234
  70. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.
    J Biol Chem. 1991 Jul 25;266(21):14064-71 PMID: 1649834
  71. Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells.
    Am J Pathol. 1992 Jan;140(1):45-55 PMID: 1731530
  72. The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases.
    Clin Nephrol. 1992 Feb;37(2):70-7 PMID: 1551253
  73. Renal injury from angiotensin II-mediated hypertension.
    Hypertension. 1992 May;19(5):464-74 PMID: 1568765
  74. Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines.
    Kidney Int. 1992 Jan;41(1):14-23 PMID: 1593850
  75. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury.
    J Am Soc Nephrol. 1994 Aug;5(2):201-9 PMID: 7993999
  76. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
    Nephrol Dial Transplant. 1994;9(10):1418-25 PMID: 7816254
  77. Myofibroblasts in experimental hydronephrosis.
    Am J Pathol. 1995 Jan;146(1):121-9 PMID: 7856721
  78. Interstitial myofibroblasts in IgA glomerulonephritis.
    Am J Nephrol. 1995;15(2):111-7 PMID: 7733146
  79. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney.
    J Clin Invest. 1995 Aug;96(2):953-64 PMID: 7635988
  80. Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases.
    Biochemistry. 1995 Sep 12;34(36):11453-9 PMID: 7547873
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2003-06-00
Pages
1937-49
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1868144
Subset
IM
Grants
NIDDK NIH HHS · K08 DK059383 · United States
NCI NIH HHS · R01 CA094121 · United States
NIDDK NIH HHS · R01 DK039776 · United States
NIDDK NIH HHS · R56 DK039776 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]